EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Alarmins and MicroRNAs, a New Axis in the Genesis of Respiratory Diseases: Possible Therapeutic Implications

Alessandro Allegra iD, Giuseppe Murdaca iD, Luca Gammeri iD, Roberta Ettari, Sebastiano Gangemi

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24021783 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Alessandro Allegra und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology, Department of Human Pathology in Adulthood and Childhood "Gaetano Barresi", University of Messina, 98125 Messina, Italy. Hauptthemen laut MEDLINE: MicroRNAs, HMGB1 Protein, Respiration Disorders. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 178 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

It is well ascertained that airway inflammation has a key role in the genesis of numerous respiratory pathologies, including asthma, chronic obstructive pulmonary disease, and acute respiratory distress syndrome. Pulmonary tissue inflammation and anti-inflammatory responses implicate an intricate relationship between local and infiltrating immune cells and structural pulmonary cells. Alarmins are endogenic proteins discharged after cell injury in the extracellular microenvironment. The purpose of our review is to highlight the alterations in respiratory diseases involving some alarmins, such as high mobility group box 1 (HMGB1) and interleukin (IL)-33, and their inter-relationships and relationships with genetic non-coding material, such as microRNAs. The role played by these alarmins in some pathophysiological processes confirms the existence of an axis composed of HMGB1 and IL-33. These alarmins have been implicated in ferroptosis, the onset of type 2 inflammation and airway alterations. Moreover, both factors can act on non-coding genetic material capable of modifying respiratory function. Finally, we present an outline of alarmins and RNA-based therapeutics that have been proposed to treat respiratory pathologies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsHMGB1 ProteinRespiration DisordersHumansAlarminsInflammation

Stichwörter der Autor:innen

acute respiratory distress syndromealarminsasthmaepigeneticshigh mobility group box 1immune responseinflammationinterleukin-33microRNAsrespiratory diseases

Substanzen

AlarminsMicroRNAsHMGB1 Protein

Autor:innen und Institutionen

  • Division of Hematology, Department of Human Pathology in Adulthood and Childhood "Gaetano Barresi", University of Messina, 98125 Messina, Italy.
  • Department of Internal Medicine, Ospedale Policlinico San Martino, 16132 Genoa, Italy.
  • Department of Clinical and Experimental Medicine, Unit and School of Allergy and Clinical Immunology, University of Messina, 98125 Messina, Italy.
  • Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, 98168 Messina, Italy.

ORCID-Profile: Alessandro Allegra, Giuseppe Murdaca, Luca Gammeri

Zitieren

APA

Allegra, A., Murdaca, G., Gammeri, L., Ettari, R., & Gangemi, S. (2023). Alarmins and MicroRNAs, a New Axis in the Genesis of Respiratory Diseases: Possible Therapeutic Implications. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24021783

Vancouver

Allegra A, Murdaca G, Gammeri L, Ettari R, Gangemi S. Alarmins and MicroRNAs, a New Axis in the Genesis of Respiratory Diseases: Possible Therapeutic Implications. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24021783

BibTeX
@article{Allegra2023,
  author = {Allegra, Alessandro and Murdaca, Giuseppe and Gammeri, Luca and Ettari, Roberta and Gangemi, Sebastiano},
  title = {Alarmins and MicroRNAs, a New Axis in the Genesis of Respiratory Diseases: Possible Therapeutic Implications},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24021783}
}
Kostenlos starten →